Sun Pharma Baska facility gets OAI status from USFDA
Mumbai: Sun Pharma has announced that the company has received Official Action Indicated (OAI) status from the U.S. Food and Drug Administration (USFDA) for Baska facility. The USFDA conducted an…
Motilal Oswal Flags 9–11% Pharma Growth in India by FY 26; Recommends Five Stocks
Motilal Oswal Wealth Management projects India’s pharmaceutical sector to grow at 9–11% by fiscal 2026 and has spotlighted five pharma and healthcare stocks—Lupin, Mankind Pharma, Piramal Pharma, IPCA Labs, and…
Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.
Sun Pharmaceutical Industries Ltd has announced that it has entered into a settlement and license agreement with Incyte Corporation regarding litigation related to LEQSELVI (deuruxolitinib). “Under the terms of agreement,…
Sun Pharma ropes in Richard Ascroft as North America CEO
Mumbai: Sun Pharma has announced the appointment of Richard Ascroft as the new North America (NAM) Chief Executive Officer (CEO). In a statement shared via LinkedIn, the company said, “We…
Sun Pharma To Sell 100 Percent Stake In Japanese Arm
Mumbai: Sun Pharmaceutical Industries Limited has entered into an agreement with Zaza Industrial Holdings K.K, Japan, under which Sun Pharma has agreed to sell 100% shares held in Sun Pharma…
